Drawing for AIXPAP

USPTO serial 98854868

AIXPAP

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
LIU, PHILIP HUAI-EN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with AIXPAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Holly Pranger

88 Guy Place, Suite 405San Francisco, CA 94105United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and apparatus for recording, transmission, and reproduction of images; Computer hardware and apparatus for image processing, namely, computers, image intensifiers, computer display monitors, and video cameras; Downloadable software for medical analysis or advisory services relating to the palliation or treatment of diseases, states, or conditions; Downloadable software for qualitative image analysis in the field of digital cytology for medical purposes; Downloadable software for quantitative image analysis in the field of digital cytology for medical purposes; Downloadable software for data ingestion, data analysis, data visualization, predictive data analysis, modeling, data preparation, digitizing data, data transformation, data augmentation, integration into a data framework, and data encryption from lab pathologies; Downloadable software for transferring slides, images, and data featuring lab cytology for disease; Downloadable software for use in displaying, viewing, storing, visualizing, filtering, assessing, and analyzing digital images; Downloadable software for use in classification and reclassifying data for medical and diagnostic purposes; Downloadable software for use in medical database management for disease diagnosis; Downloadable software for use in analyzing data of cancerous diseases; Downloadable software for data analysis; Downloadable software for data processing; Downloadable software for diagnosing diseases for medical purposes; Downloadable software for scientific and technical analysis of data using artificial intelligence (AI); Downloadable software using artificial intelligence for diagnosing diseases for medical purposesACTIVE—
010Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology, and cell-based testing; Medical diagnostic apparatus with computer displays, computer hardware, and recorded software for processing medical imagesACTIVE—
042Providing online non-downloadable software for artificial intelligence processing, machine learning, deep learning, statistical learning, data mining, and contextual prediction; Providing online non-downloadable software for reading digital slides; Providing online non-downloadable software for use in diagnosis of diseases, states, or conditions; Providing online non-downloadable software for use in evaluation of prognosis relating to diseases, states, or conditions; Providing online non-downloadable software for use in research or development in the field of cytology; Providing online non-downloadable software using artificial intelligence for cancer detection, decision support and image analysis for healthcare; Providing online non-downloadable software using artificial intelligence and machine learning for medical diagnostic use in the fields of cancer or other tissue-based diagnostic testing, cytology, and cell-based testing; Providing online non-downloadable software for scanning, viewing, analyzing, annotating, storing, compiling, sharing, reviewing, enhancing, and managing medical image data; Digital pathology services, in particular web-based pathology services in the nature of providing online non-downloadable software for scanning, viewing, analyzing, annotating, storing, compiling, sharing, reviewing, enhancing, and managing medical image data; Providing online non-downloadable software for processing digital imagesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 28, 2026EXT1SOU EXTENSION 1 FILED—
Jul 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 11, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 12, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2025DOCKASSIGNED TO EXAMINER—
Apr 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance